NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Coloplast A/S (CO: COLO-B)

 
COLO-B Technical Analysis
1
As on 27th Aug 2024 COLO-B STOCK Price closed @ 924.20 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

COLO-BSTOCK Price

Open 922.60 Change Price %
High 929.40 1 Day N/A N/A
Low 922.40 1 Week 0.00 0.00
Close 924.20 1 Month 0.00 0.00
Volume 179969 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
CO Denmark Most Active Stocks
SAS 0.01 %
NOVO-B 904.10 %
ALMB 11.91 %
VWS 153.10 %
BAVA 273.00 %
ASTRLS 1.15 %
GN 159.00 %
BLVIS-A 0.40 -18.37%
DANSKE 206.10 %
NDA-DK 79.32 %
 
CO Denmark Top Gainers Stocks
DKIEEU 249.00 15.81%
SYILATKL 237.20 3.40%
CWIGAAKKKL 200.80 3.03%
CWIASKL 243.70 2.65%
JYIKIKL 82.00 2.50%
CWIGAEKL 152.45 2.45%
CWIGAKL 1010.60 2.37%
AOJ-P 88.00 2.33%
CWISAKTKL 177.60 1.92%
NZYM-B 323.50 1.67%
 
CO Denmark Top Losers Stocks
BLVIS-A 0.40 -18.37%
VIPRO 0.88 -4.35%
SEIJHP 103.85 -3.53%
LSIDKA 121.13 -3.29%
SYVAAA 147.59 -2.68%
AUDNTS 5.50 -2.48%
HAINOR 106.06 -2.16%
SYVVUA 100.70 -2.14%
SYIVLVADKKA 162.76 -2.10%
SEIBVP 195.40 -2.03%
 
 
COLO-B
Daily Charts
COLO-B
Intraday Charts
Whats New @
Bazaartrend
COLO-B
Free Analysis
 
COLO-B Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
COLO-B Forecast September 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
COLO-B Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
COLO-B Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
COLO-B Other Details
Segment EQ
Market Capital 226546794496.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
COLO-B Address
COLO-B
 
COLO-B Latest News
 
Your Comments and Response on Coloplast A/S
 
COLO-B Business Profile
Coloplast A/S develops and markets intimate healthcare products and services worldwide. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catheterization for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark. Address: Holtedam 1-3, Humlebæk, Denmark, 3050
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service